日本拟将外国人签证手续费上调至现行的5倍 原创 阅读全文 日经GO ...

在地面上大量建设AI数据中心会导致电力不足，进行冷却也需要大量水。而在太空，光伏电池 的发电效率最高可达地面的8倍，向太空释放废热也无需冷却水。美国科技巨头开始推进太空 数据中心构想…… 美国科技企业正在推进在太空建立用于AI的数据中心的构想。谷歌计划2027年发射人造卫 星，SpaceX和OpenAI也显示出兴趣。英伟达正在为发射搭载AI半导体的人造卫星的企业提 供支援。太空数据中心有可能替代正在激增的用于AI的地面基础设施。 在人造卫星设置服务器，24小时以太阳能供电 太空数据中心是在地球轨道上的人造卫星上设置服务器，在宇宙空间进行数据处理和存储的 机制。各企业正在描绘通过群控拥有计算和通信能力的人造卫星来替代地面数据中心的构 想。 电力可以在宇宙空间利用光伏电池昼夜发电。由于地面数据中心在未来难以确保所需的大量 电力和水，太空数据中心作为未来基础设施的形态而迅速受到关注。 从火箭分离的搭载英伟达半导体的Starcloud的首颗卫星（11月、引自SpaceX官方网站） "这是在宇宙空间中扩大机器学习计算能力的大胆挑战"。谷歌在11月公布了太空数据中心项 目"太阳捕手"计划（Project Suncatch ...

高市早苗在东证2025年最后一个交易日敲钟（12月30日） 2026年，高市早苗政府的积极财政政策给市场带来的风险成为焦点。高市强调"确保市场的 信任"，但警惕感正在增强。高市的首个难关是1月下旬召开的日银货币政策决定会议…… 日本银行（央行）上调政策利率之后，日元贬值趋势仍在持续。2026年，高市早苗政府的积 极财政政策给市场带来的风险成为焦点。高市强调"确保市场的信任"，但警惕感正在增强。 要获得市场信任有三大难关。 第一个难关是1月22~23日召开的日银货币政策决定会议。日银总裁植田和男显示出2026年 也将维持加息路线的态度。3、4月也将举行货币政策决定会议。 尽管在2025年12月的会议上将政策利率上调至0.75%，达到30年来的最高水平，但目前日 元汇率仍处在1美元兑155日元区间，呈现日元贬值态势。美国联邦储备委员会（FRB）在同 一时期决定降息，通常情况下本应呈现利息差缩小、转向日元升值的局面。 如果日银无法扭转日元贬值预期，可能出现汇率干预的利弊受到拷问的情况。 日本内阁官房长官木原稔在12月22日的记者招待会上就外汇市场表示"出现了单向的急剧波 动，令人担忧"。他表示日本政府"将对过度的波 ...

Core Viewpoint - Suzuki plans to start domestic production of lightweight electric vehicles (EVs) in Japan by the fiscal year 2026, aiming to maintain a production scale of 1 million vehicles domestically, which is crucial for sustaining the supply chain [2][5]. Group 1: Production Plans and Strategy - Suzuki will begin producing lightweight EVs at its Kakegawa plant in Shizuoka Prefecture in the fiscal year 2026, with specific launch dates and pricing yet to be announced [4]. - The company has historically viewed a domestic production target of 1 million vehicles as essential for supply chain stability, but production has frequently fallen below this threshold in the past decade [5]. - To counteract the decline in domestic sales of lightweight vehicles, which have dropped by 18% from 2015 levels, Suzuki is increasing production in India, which has become a key export base [5]. Group 2: Market Context and Challenges - The overall sales of lightweight vehicles in Japan are projected to decline by 18% to approximately 1.56 million units by 2024, compared to 2015, which is a larger drop than the 9% decline in regular vehicle sales [5]. - The COVID-19 pandemic significantly impacted Suzuki's sales, bringing them to a 30-year low in 2021, although there is a current recovery trend [5]. - The shift in production strategy is also influenced by rising inflation and high tariffs, prompting Japanese automakers to reconsider their domestic production models [6].

Core Viewpoint - Japan's Engel coefficient has reached a record high of 29.4% in Q3 2025, indicating a significant burden on food spending amidst persistent food inflation [2][5][7]. Group 1: Engel Coefficient and Food Inflation - The Engel coefficient for Japan in Q3 2025 is 29.4%, the highest since the current standard was adopted in 2000, with a moving average of 28.4% for the last four quarters [2][5]. - Japan's Engel coefficient was already the highest among G7 countries in 2024, with the lowest being around 16% in the United States, indicating a stark difference in food spending [7][9]. - Food prices in Japan have shown a year-on-year increase of around 6%, with specific items like chocolate and coffee beans experiencing significant price hikes due to high import costs [7][9]. Group 2: Household Financial Pressure - Real wages in Japan have seen negative growth for ten consecutive months as of October 2025, exacerbating financial pressure on households [9][10]. - The average proportion of disposable income spent on food for households of two or more was nearly 19% from January to October 2025, higher than previous years [9][10]. - Households are reaching their limits in cutting food spending, indicating a need for a shift in strategy to manage overall expenses [10][11]. Group 3: Strategies for Financial Management - Households are encouraged to reassess fixed expenditures such as housing, communication, and insurance to find areas for potential cuts [11]. - Despite ongoing wage increases, concerns about corporate salary adjustments have risen, potentially leading to stagnation in salary growth [11]. - Families are advised to explore various strategies, including job changes, to cope with inflationary pressures [11].

Core Insights - The West Bund area in Shanghai has transformed into a new landmark attracting many trend-sensitive young people after redevelopment [2][4] - The redevelopment involved the participation of the Japanese architectural firm "Nikken Sekkei," which applied experiences from the redevelopment of Shibuya Station in Tokyo [2][5] Group 1: Redevelopment Overview - The West Bund is located along the Huangpu River in Xuhui District, spanning approximately 11 kilometers, and was previously an industrial zone with cement factories and an airport [4] - The area has seen the opening of art museums and commercial facilities, with major companies like Alibaba establishing offices there [4] Group 2: Urban Design and Planning - Nikken Sekkei was involved in the overall planning of a section called "Media Port," which features multiple buildings interconnected by pedestrian-friendly spaces [5] - The design includes underground passages for easy movement between buildings and elevated walkways to enhance pedestrian flow [5] - Key nodes known as "Urban Core" have been established to facilitate vertical movement using escalators and stairs, similar to the Shibuya redevelopment project [5] Group 3: Community Engagement - The area has become popular among young pet owners, with many pet-friendly shops attracting visitors despite the distance from their homes [4]

Core Viewpoint - The article discusses the current economic situation in China, the challenges faced by Japanese companies in the Chinese market, and the potential opportunities that still exist despite geopolitical tensions [2][3][5]. Group 1: Current Economic Situation in China - The adjustment in China's real estate market is not yet complete, and the economy is expected to face severe challenges until 2026. The potential returns from real estate investments are decreasing, and personal consumption is facing headwinds [3]. - The Chinese government is attempting to increase investments in infrastructure and advanced technologies like AI, but these efforts are insufficient to boost economic growth rates [3]. Group 2: Japanese Companies' Response to China - Japanese companies should cautiously explore opportunities in China while managing risks. There are still potential markets for products and services favored by Chinese consumers, despite the ongoing Japan-China tensions [7]. - Companies that have developed low-cost, high-quality food services in Japan are successfully entering the deflationary Chinese market [7]. Group 3: Opportunities in Chinese Products and Technology - China has a wealth of engineering talent, and its humanoid robots have set Guinness World Records for walking distances. These robots could be useful in Japan, especially in sectors facing labor shortages [8]. - Chinese products, such as BYD's electric vehicles and Huawei's smartwatches, are not only competitively priced but also of high quality. However, there are psychological barriers among Japanese consumers regarding Chinese products that need to be addressed [8]. Group 4: Itochu Corporation's Future Plans - Itochu Corporation aims to achieve the highest consolidated net profit among general trading companies for the fiscal year ending March 2026, with a target of exceeding 900 billion yen [9].

Core Viewpoint - The Nikkei average index closed above 50,000 points for the first time, driven by global expectations for generative AI and stable inflation in Japan, with a 26% increase in 2025, outperforming the US Dow Jones for three consecutive years [2][4]. Group 1: Market Performance - The Nikkei average index closed at 50,339 points on December 30, down 0.4% from the previous day, but still marked the highest year-end point for two consecutive years [4]. - Global stock market capitalization reached $146 trillion, increasing by $25 trillion (20%) over the year, with almost all major countries experiencing stock index gains [4]. Group 2: Economic Factors - Major countries' monetary easing has led to abundant investment funds, with the US Federal Reserve expected to cut rates three times and the European Central Bank four times by 2025 [6]. - The rise of AI-related stocks in the US has mirrored global trends, with significant investments in data center equipment by major tech companies like Microsoft [6]. Group 3: Japanese Market Dynamics - Japanese AI-related stocks, such as Advantest, SoftBank Group, and Tokyo Electron, are expected to benefit from increased demand, significantly boosting the Nikkei index [7]. - The Japanese stock market's performance has been notably strong, with a 14% increase in 2025, marking the first time since the 1989 bubble that it has outperformed the US Dow Jones for three consecutive years [7][8]. Group 4: Inflation and Corporate Earnings - Japan's inflation has stabilized, with consumer price increases exceeding the government's 2% target since April 2022, leading to expectations of wage increases of over 5% in 2026 [7][8]. - The expected earnings per share (EPS) for TOPIX constituents have reached 2.2 times the levels seen at the end of 2020, slightly surpassing the S&P 500's growth [8]. Group 5: Foreign Investment and Policy Implications - Foreign investors purchased over 5 trillion yen in Japanese stocks this year, the largest since the first year of Abenomics in 2013 [8]. - The new government's aggressive economic policies may pose risks to stock price increases, as fiscal expansion under inflation could lead to concerns about economic growth and fiscal health [8].

Core Viewpoint - Chinese companies are leading the world in cancer clinical trials, with a projected 39% share in 2024, surpassing the United States at 32% and indicating a significant shift in the global pharmaceutical landscape [1][3]. Group 1: Clinical Trials and Market Position - In 2024, Chinese enterprises are expected to conduct 896 cancer clinical trials, representing 39% of the global total, while the U.S. will account for approximately 32% [3]. - The number of clinical trials conducted by Chinese companies has increased from about 2% in 2009 to 35% in 2023, marking a substantial growth trajectory [3]. - The global market for pharmaceuticals is projected to see China’s drug expenditure reach $166 billion in 2024, constituting 10% of the global market [9]. Group 2: Government Support and R&D Investment - The Chinese government has prioritized new drug research as a key area, providing substantial funding and talent, particularly in the biopharmaceutical sector [7]. - The "Made in China 2025" initiative has identified biomedicine as a critical industry for national revitalization [7]. Group 3: Collaborations and Partnerships - Japanese pharmaceutical companies are increasingly collaborating with Chinese firms, with notable agreements for cancer treatments and other therapeutic areas [8]. - In the first half of 2025, contracts between Chinese and global pharmaceutical companies reached 61, totaling $48.5 billion, indicating a growing trend in international partnerships [9]. Group 4: Innovation and Patent Applications - China applied for over 188,000 drug patents in 2024, significantly outpacing the U.S. with approximately 53,000 applications, showcasing an increase in R&D capabilities [9]. - The quality of drug development in China is improving, with expectations for the emergence of blockbuster drugs and major pharmaceutical companies in the future [9]. Group 5: Global Market Challenges - Despite advancements, Chinese drugs primarily remain within the domestic market, with challenges in gaining approval for international sales [11]. - The need for transparent clinical trial data and intellectual property protection is crucial for Chinese companies aiming for global market entry [12].

Core Viewpoint - The opening of the ONE PIECE BASE SHOP in Shinjuku, which took place on December 5, 2025, was met with overwhelming foot traffic, leading to the suspension of sales the following day due to operational challenges [3][5]. Group 1 - The ONE PIECE BASE SHOP is located on the fourth floor of the Shinjuku Marui department store and is dedicated to the popular manga series "One Piece" [3]. - The opening ceremony on November 26, 2025, featured notable attendees including Nakano Hiroyuki, the deputy editor of Shueisha's third editorial department, and Kawasaki Hiroshi, the president of Bandai Namco Experience [5]. - The store's initial operations were disrupted by unexpectedly high customer turnout, prompting a temporary halt in sales starting December 6, 2025, with plans to resume on January 13, 2026 [5].